REMICADE

Powder for concentrate for solution for infusion, 100mg
RxActive license

Active substance (INN)

infliximab

Pharmaceutical form

Pharmaceutical formPowder for concentrate for solution for infusion
Strength100mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerJanssen Biologics B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L04AB02)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateMay 23, 2024

Analogs in Montenegro

1

Other medicines with the same active substance

INFLECTRARx
Powder for concentrate for solution for injection, 100mgHospira Zagreb d.o.o.
Source: CInMED register